Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AMAG | AMGN | BMY | VRTX | GILD |
| Company | Amag Pharmaceuticals | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 13.75 | 275.81 | 58.57 | 454.72 | 92.59 |
| High | 13.76 | 278.55 | 58.79 | 462.02 | 92.60 |
| Low | 13.75 | 273.86 | 57.59 | 450.00 | 89.86 |
| Last | 13.75 | 278.88 | 58.32 | 459.42 | 91.50 |
| Change | +0.02 | +0.56 | -0.37 | +2.45 | -0.99 |
| % Change | +0.15% | +0.20% | -0.63% | +0.54% | -1.07% |
| Volume | 1,534,500 | 1,882,570 | 4,478,878 | 628,011 | 3,857,685 |
| 20-Day Average Volume | 1,378,455 | 4,439,784 | 11,261,715 | 1,363,249 | 7,360,870 |
| Previous Close | 13.73 | 278.32 | 58.69 | 456.97 | 92.49 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 13.70 | 293.66 | 57.96 | 472.95 | 92.01 |
| 20-Day Raw Stochastic | 93.33% | 28.86% | 63.36% | 17.96% | 40.87% |
| 20-Day Relative Strength | 69.51% | 33.84% | 58.45% | 44.73% | 54.63% |
| Weighted Alpha | +24.20 | -4.63 | +25.12 | +21.13 | +24.26 |
| Today's Opinion | 100% Buy | 72% Sell | 100% Buy | 8% Sell | 88% Buy |
| Previous Opinion | 100% Buy | 72% Sell | 100% Buy | 8% Sell | 100% Buy |
| Last Month's Opinion | 100% Buy | 8% Buy | 88% Buy | 24% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.22% since 11/06/20 | -0.67% since 11/26/24 | -0.45% since 11/26/24 | -1.85% since 11/26/24 | -0.03% since 11/26/24 |
| Low | 13.71 on 11/10/20 | 273.86 on 12/04/24 | 57.59 on 12/04/24 | 451.05 on 12/04/24 | 89.86 on 12/04/24 |
| High | 13.76 on 11/13/20 | 283.64 on 11/29/24 | 60.09 on 12/03/24 | 470.93 on 11/29/24 | 94.39 on 12/03/24 |
| 1-Month | |||||
| %Chg | +2.84% since 10/13/20 | -12.24% since 11/04/24 | +5.46% since 11/04/24 | -3.04% since 11/04/24 | +1.65% since 11/04/24 |
| Low | 13.35 on 10/14/20 | 257.80 on 11/26/24 | 53.97 on 11/08/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 13.76 on 11/13/20 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +30.09% since 08/13/20 | -15.88% since 09/04/24 | +17.04% since 09/04/24 | -4.21% since 09/04/24 | +15.41% since 09/04/24 |
| Low | 8.62 on 09/24/20 | 257.80 on 11/26/24 | 47.55 on 09/09/24 | 445.00 on 11/21/24 | 77.74 on 09/05/24 |
| High | 13.80 on 10/01/20 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +87.33% since 05/13/20 | -9.51% since 06/04/24 | +40.06% since 06/04/24 | -3.48% since 06/04/24 | +42.33% since 06/04/24 |
| Low | 6.51 on 05/14/20 | 257.80 on 11/26/24 | 39.35 on 07/05/24 | 445.00 on 11/21/24 | 62.69 on 06/18/24 |
| High | 13.80 on 10/01/20 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 477,469 | 149,606,192 | 119,033,712 | 117,683,024 | 115,267,136 |
| Shares Outstanding, K | 34,725 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 327,750,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -466,460,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 52,760,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -13,240,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 0.89 | 0.55 | 0.45 | 0.36 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/13/20 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.47 | 51.23 | 0.00 | 21.22 |